
Planet 13 Holdings Inc.
100
Recent news highlights mixed financial performance for Planet 13, including reports of revenue growth amid challenges and a prior quarter revenue decline. Broader market news and sector-related investor takeaways are also noted.
- Planet 13 showed revenue growth amid challenges according to a recent report [N3].
- Earlier, Planet 13 reported a 14% revenue drop in Q2, indicating variability in financial performance [N3].
- Broader market and sector news include various key takeaways for long-term investors in related industries [N3].
- Agricultural commodity markets such as wheat and corn posted gains and firmed into the weekend, reflecting broader market activity [N1][N2].
Planet 13 Holdings Inc. is a vertically integrated cannabis company operating in multiple U.S. states including Nevada, California, Illinois, and Florida. It holds numerous licenses for cultivation, production, retail dispensaries, and distribution. The company manufactures cannabis products under several brands and maintains a large customer loyalty database. Its operations are conducted through various wholly owned subsidiaries specializing in different aspects of the cannabis business and related real estate holdings. The company has reported quarterly revenues and net losses, with liquidity ratios suggesting it maintains sufficient current assets relative to liabilities. Planet 13 is engaged in a pending merger with Vireo Health International, which may impact its future business operations and shareholder structure.
Planet 13 Holdings Inc. operates as a vertically integrated cannabis company with licenses and operations across Nevada, California, Illinois, and Florida. The company holds multiple cultivation, production, dispensary, and distribution licenses and owns several cannabis product brands. As of September 30, 2026, it reported quarterly revenue of $23.08 million and a net loss of $6.36 million, with liquidity ratios indicating moderate short-term financial stability. The company is currently involved in a merger process with Vireo Health International, which introduces regulatory and operational uncertainties. Recent news highlights mixed revenue performance and ongoing business challenges. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
Planet 13 benefits from a diversified and vertically integrated cannabis business model with licenses in multiple states, enabling it to capture value across the supply chain. Its portfolio of proprietary brands and a large customer loyalty base provide opportunities for revenue growth and customer engagement. The company's liquidity position and asset base support ongoing operations and potential expansion. The pending merger with Vireo Health International could provide strategic benefits through combined resources and market reach.
The company has reported net losses and variability in revenue, indicating operational and market challenges. The cannabis industry remains subject to complex and evolving regulatory environments that may impact licenses and operations. The pending merger introduces execution risks, including regulatory approvals and integration challenges. Liquidity ratios suggest moderate short-term financial flexibility but limited cash reserves relative to liabilities. Market uncertainties and competitive pressures could adversely affect business performance and shareholder value.
Planet 13's moat is derived from its vertically integrated cannabis operations across multiple regulated U.S. states, supported by a broad portfolio of licenses covering cultivation, production, retail, and distribution. The company’s established brands and a sizable customer loyalty database enhance customer retention and market presence. Its diversified geographic footprint and regulatory licenses create barriers to entry for competitors. Additionally, ownership of real estate and intellectual property subsidiaries supports operational control and potential cost advantages.
• Regulatory and Licensing Risks: Planet 13 operates in a highly regulated cannabis industry with licenses subject to state regulatory approvals and compliance. Changes in laws or failure to maintain licenses could materially impact operations.
• Merger Execution Risks: The pending merger with Vireo Health International is subject to multiple conditions and regulatory approvals. Failure to complete the merger or integration challenges could disrupt business and affect financial results.
• Financial Performance and Liquidity Risks: The company reported net losses and has limited cash reserves relative to liabilities. Continued losses or inability to raise capital could constrain operations and growth.
• Market and Competitive Risks: The cannabis market is competitive and evolving. Changes in consumer preferences, competition, or market conditions could adversely affect revenue and profitability.
Business trends: The company operates across multiple states with a vertically integrated cannabis model and a portfolio of proprietary brands, showing variable revenue performance amid industry challenges.
Execution milestones: Completion of the pending merger with Vireo Health International and integration of operations; maintaining regulatory compliance and license renewals.
Key risks: Regulatory uncertainties in cannabis markets, merger execution and integration risks, financial performance variability, and competitive market pressures.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Planet 13 Holdings Inc. is a vertically integrated cultivator and provider of cannabis and cannabis-infused products operating in Nevada, California, Illinois, and Florida [S1].
- The company holds multiple licenses in Nevada for cultivation (3 medical, 3 adult-use), production (3 medical, 3 adult-use), dispensaries (1 medical, 2 adult-use), and distribution (adult-use and medicinal) [S1].
- In California, subsidiaries hold one medium indoor cultivation license, one manufacturing license, two distribution licenses, one dispensary license, and one event organizer license [S1].
- In Florida, the company holds a Medical Marijuana Treatment Center license allowing operation of multiple dispensaries (33 as of December 31, 2025), cultivation facilities (one operational), and manufacturing facilities (one operational) [S1].
- In Illinois, the company holds one adult-use dispensing license [S1].
- Planet 13 owns and manufactures cannabis products under brands including HaHa, Dreamland, TRENDI, Medizin, and Leaf and Vine, with a customer loyalty database exceeding 485,000 customers [S1].
- The company operates through multiple wholly owned subsidiaries for license holding, retail sales, cultivation, manufacturing, intellectual property, and real estate [S1].
- As of September 30, 2026, Planet 13 reported cash and equivalents of $5.79 million, current assets of $36.04 million, current liabilities of $21.28 million, resulting in a current ratio of 1.69 and a cash ratio of 0.27 [S2].
- Revenue for the quarter ended September 30, 2026 was $23.08 million, with a net loss of $6.36 million and basic EPS of -$0.02 [S2].
- The company is engaged in a pending merger with Vireo Health International, subject to multiple regulatory and shareholder approvals, which may affect business operations and stockholder interests [S2].
- Recent news includes reports on Planet 13's revenue showing growth amid challenges and a prior report of a 14% revenue drop in Q2, indicating variability in financial performance [N3].
Generated 2026-11-15
- S1 | 2026-03-25 | 10-K
- S2 | 2026-11-12 | 10-Q
- N1 | 2026-11-15 | www.nasdaq.com | Wheat Posts Friday Gains | https://www.nasdaq.com/articles/wheat-posts-friday-gains-0
- N2 | 2026-11-15 | www.nasdaq.com | Corn Firm into the Weekend as Export Business Picks Up | https://www.nasdaq.com/articles/corn-firm-weekend-export-business-picks
- N3 | 2026-11-15 | www.nasdaq.com | Honeywell Aerospace: 3 Key Takeaways for Long-Term Investors | https://www.nasdaq.com/articles/honeywell-aerospace-3-key-takeaways-long-term-investors
- N4 | 2026-11-15 | www.nasdaq.com | Nov. 25 Will Be a Critical Day for the Stock Market | https://www.nasdaq.com/articles/nov-25-will-be-critical-day-stock-market
- N5 | 2026-11-15 | www.nasdaq.com | EZCORP: 3 Key Takeaways for Long-Term Investors | https://www.nasdaq.com/articles/ezcorp-3-key-takeaways-long-term-investors
- N6 | 2026-11-15 | www.nasdaq.com | Legacy Education: 3 Key Takeaways for Long-Term Investors | https://www.nasdaq.com/articles/legacy-education-3-key-takeaways-long-term-investors
- N7 | 2026-11-15 | www.nasdaq.com | Nu Holdings: 3 Key Takeaways for Long-Term Investors | https://www.nasdaq.com/articles/nu-holdings-3-key-takeaways-long-term-investors
- N8 | 2026-11-15 | www.nasdaq.com | LifeMD: 3 Key Takeaways for Long-Term Investors | https://www.nasdaq.com/articles/lifemd-3-key-takeaways-long-term-investors
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


